MCB

Longtime Urbana resident Eric Jakobsson is being remembered as a devoted husband and father, a brilliant scientist and mentor, a political bridge-builder and all-around nice guy.

The School of Molecular & Cellular Biology is pleased to announce the winners of its annual Undergraduate Research Symposium.

Researchers at the University of Illinois Urbana-Champaign are hopeful their findings on the gating mechanisms behind epilepsy-associated potassium channels could provide a foundation for new therapeutic strategies for treating epilepsy, especially in young patients. Their research was recently...

Biochemistry researchers at the University of Illinois Urbana-Champaign are conducting trailblazing work on a group of conserved proteins that are directly related to abnormal cell proliferation and developmental and neurological disorders. In a new article published in Cell Reports, biochemistry...

This Veterans Day, student researcher Elizabeth Spurlock reflects on her experience investigating issues related to brain health in populations who have served. Her research is conducted in partnership with the Beckman Institute and the Chez Veteran Center at the University of Illinois Urbana-...

For the past few decades, scientists have observed a trend of increased height and younger age of puberty onset in humans. Now, research outlining a new pathway in humans linking body fat to puberty onset and growth could provide an explanation as to why these changes are occurring. Their findings...

In a study reported in the journal Chemical Science, researchers developed a new method to determine how antibiotics with specific chemical properties thread their way through tiny pores in the otherwise impenetrable cell envelopes of Gram-negative bacteria.

Thanks to the installation of a cryogenic electron microscope at the University of Illinois, researchers are exploring what was once hidden or difficult to study at the molecular level.

The School of Molecular & Cellular Biology partnered with the eClose Institute to offer a new program for middle and high school students from historically excluded groups that introduces them to scientific research opportunities.

From helping bring a powerful, first-in-class HIV treatment to market to his most recent position as the CEO and co-owner of a preclinical contract research organization, Michael Recny (PhD, biochemistry, ’83) has paved a successful career path in the biotechnology industry, a field that was just...